Petriage awarded U.S. patent for telehealth technology
This is Petriage’s second U.S. patent which will extend its AI-driven symptom analysis tool to telemedicine extending beyond pets
Petriage, a pet health technology company, announced in an organizational release1 that the U.S. Patent and Trademark Office awarded them a new patent to be issued on June 7, 2022. This patent is the company’s second, and it encompasses teletriage for all animals, including humans.
With this new patent, Petriage plans to further develop its unique AI-driven symptom analysis and triage technology to provide similar telehealth solutions for human health care. These developments include a symptom analysis tool to identify human ailments with increasing levels of urgency, virtual consultations with physicians, and automated remote monitoring.1
Petriage was designed to bring fully integrated telehealth services to veterinary practices and their clients. The company’s platform provides a way for vets to communicate with clients and deliver care to pets remotely, including a proprietary patented teletriage app in which pet parents are provided a recommendation in real-time about the need and urgency to seek medical care for their pets.
When Petriage applied for a patent on its pet evaluation and triage system, which the U.S. Patent and Trademark Office granted in February 2021 for 20 years, the company also began a long-term track to approve a patent that widens the scope and language to encompass all animals.
Joe Coury, Petriage's chief executive officer, spoke on this technological development and the extension to human health by stating, “We could envision using such learnings to provide humans with the right telehealth information at the right time.”1
Co-founders Shlomo Freiman, DVM, Casey Olives, Ph.D., and Allon Freiman developed the company’s algorithm and system analysis tool.
“Our original impetus was to empower vets like me and provide their clients with peace of mind by leveraging AI to deliver remote patient care," said Freiman. “But the 97%-plus accuracy of the AI-driven symptom analysis tool has exceeded what we initially envisioned.”
Olives added, “What has proved so exciting is that our unique machine learning model for health data is demonstrating how to marry the clinical side with the data science side, first with pets and now potentially for humans.”1
Petriage awarded U.S. patent for AI-driven telehealth technology beyond pets. News release. Petriage. May 20, 2022.